Janssen-Cilag AG Release: ZYTIGA® Approved in the EU for Use in the Treatment of Metastatic Castration-Resistant Prostate Cancer Before Chemotherapy
1/11/2013 10:00:52 AM
More...
|
Janssen-Cilag AG Acquires CorImmun
6/28/2012 10:31:03 AM
More...
|
Basilea Pharmaceutica (BSLN.SW) Announces Discontinuation of Sale of Ceftobiprole by Janssen-Cilag AG, a Johnson & Johnson (JNJ) Company, In Switzerland
9/9/2010 7:03:45 AM
More...
|
Janssen-Cilag AG Submits Marketing Authorisation Application in Europe for Paliperidone Palmitate for the Treatment of Schizophrenia
12/4/2009 10:14:44 AM
More...
|
Janssen-Cilag AG Announces CHMP Delays European Commission Decision Process to Approve ZEVTERATM
2/24/2009 7:58:43 AM
More...
|
PPD, Inc. (PPDI) to Receive Milestone Payments for First Regulatory Approvals of Priligy(TM) (Dapoxetine) in Finland and Sweden for Treatment of Premature Ejaculation
2/10/2009 10:07:18 AM
More...
|
Janssen-Cilag AG's Priligy(TM) (Dapoxetine) Receives First Regulatory Approvals for the Treatment of Premature Ejaculation (PE) in Finland and Sweden
2/10/2009 6:59:29 AM
More...
|
Janssen-Cilag AG New Biologic STELARA(TM) Receives Approval in Europe for Treatment of Moderate to Severe Plaque Psoriasis
1/22/2009 10:42:20 AM
More...
|
Janssen-Cilag AG's New Antibiotic Against Serious Infections - Receives First Approval in Europe
11/13/2008 7:26:08 AM
More...
|
Janssen-Cilag Release: Submission of Marketing Authorization Application for Dapoxetine in Europe
12/7/2007 6:40:53 AM
More...
|
|